MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
Total Valuation
MediPharm Labs has a market cap or net worth of $19.79M. The enterprise value is $16.74M.
Market Cap$19.79M
Enterprise Value$16.74M
Share Statistics
MediPharm Labs has 420,755,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding420,755,000
Owned by Insiders9.43%
Owned by Institutions―
Financial Efficiency
MediPharm Labs’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -23.35%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-23.35%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee280.27K
Profits Per Employee-51.35K
Employee Count161
Asset Turnover0.99
Inventory Turnover3.89
Valuation Ratios
The current PE Ratio of MediPharm Labs is ―. MediPharm Labs’s PEG ratio is 0.13.
PE Ratio―
PS Ratio0.61
PB Ratio0.76
Price to Fair Value0.76
Price to FCF-4.88
Price to Operating Cash Flow-4.97
PEG Ratio0.13
Income Statement
In the last 12 months, MediPharm Labs had revenue of 45.12M and earned -8.27M in profits. Earnings per share was -0.02.
Revenue45.12M
Gross Profit13.97M
Operating Income-8.41M
Pretax Income-8.27M
Net Income-8.27M
EBITDA-6.54M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -5.50M and capital expenditures -100.00K, giving a free cash flow of -5.60M billion.
Operating Cash Flow-5.50M
Free Cash Flow-5.60M
Free Cash Flow per Share-0.01
Dividends & Yields
MediPharm Labs pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.03
52-Week Price Change-14.04%
50-Day Moving Average0.05
200-Day Moving Average0.05
Relative Strength Index (RSI)51.86
Average Volume (3m)283.50K
Important Dates
MediPharm Labs upcoming earnings date is May 18, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
MediPharm Labs as a current ratio of 2.77, with Debt / Equity ratio of 0.56%
Current Ratio2.77
Quick Ratio1.96
Debt to Market Cap<0.01
Net Debt to EBITDA1.62
Interest Coverage Ratio-133.46
Taxes
In the past 12 months, MediPharm Labs has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MediPharm Labs EV to EBITDA ratio is -2.56, with an EV/FCF ratio of -2.99.
EV to Sales0.37
EV to EBITDA-2.56
EV to Free Cash Flow-2.99
EV to Operating Cash Flow-3.04
Balance Sheet
MediPharm Labs has $10.81M in cash and marketable securities with $201.00K in debt, giving a net cash position of $10.61M billion.
Cash & Marketable Securities$10.81M
Total Debt$201.00K
Net Cash$10.61M
Net Cash Per Share$0.03
Tangible Book Value Per Share$0.08
Margins
Gross margin is 30.95%, with operating margin of -18.63%, and net profit margin of -18.32%.
Gross Margin30.95%
Operating Margin-18.63%
Pretax Margin-18.32%
Net Profit Margin-18.32%
EBITDA Margin-14.50%
EBIT Margin-18.18%
Analyst Forecast
The average price target for MediPharm Labs is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―